Fox Run Management, L.L.C. Ptc Therapeutics, Inc. Transaction History

Fox Run Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$24.69 - $40.12 $691,245 - $1.12 Million	27,997 New	27,997 $856,000
Q4 2023 Feb 13, 2024	BUY	$18.07 - $29.37 $133,989 - $217,778	7,415 New	7,415 $204,000
Q4 2018 Jan 15, 2019	SELL	$29.83 - $46.51 $328,637 - $512,400	-11,017 Closed	0 $0
Q3 2018 Oct 05, 2018	SELL	$33.9 - $47.77 $33,459 - $47,148	-987 Reduced 8.22%	11,017 $518,000
Q2 2018 Jul 17, 2018	BUY	$25.7 - $47.88 $308,502 - $574,751	12,004 New	12,004 $405,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.